Edison Healthcare Insight report - August 2015. Prima Biomed is mentioned on page 42 of 58...
http://www.google.com.au/url?sa=t&rct=j&q=&esrc=s&source=web&cd=9&ved=0CE0QFjAIahUKEwiPkrahr7nHAhUkIaYKHQ2IBo8&url=http://www.edisoninvestmentresearch.com/?ACT=19&ID=14694&dir=monthlybooks&field=19&ei=MK3WVY-6L6TCmAWNkJr4CA&usg=AFQjCNGY7Ak6ocHa4byCxfoWeWUy25uKcA&sig2=ABboT3KbJ1S1lAlITj3Gbg
Immunotherapies are among the most promising class of products for cancer andenhanced and more efficient production platform.
autoimmune diseases. The LAG-3 products are potentially first-in-class, each with distinct
mechanisms and applications. CVac is a similar treatment to Dendreon's Provenge, with an
- Forums
- ASX - By Stock
- Prima Biomed - Undervalued Biotech!
Edison Healthcare Insight report - August 2015. Prima Biomed is...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.0¢ |
Change
0.025(6.85%) |
Mkt cap ! $566.5M |
Open | High | Low | Value | Volume |
37.0¢ | 39.3¢ | 36.8¢ | $1.090M | 2.850M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 58838 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 380481 | 24 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 33342 | 0.390 |
15 | 65410 | 0.385 |
16 | 110692 | 0.380 |
13 | 198189 | 0.375 |
6 | 262165 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 380481 | 24 |
0.400 | 294816 | 18 |
0.405 | 35634 | 4 |
0.410 | 205436 | 5 |
0.415 | 95531 | 4 |
Last trade - 14.33pm 30/08/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online